Roche’s RoACTEMRA receives EU approval for use in patients with early rheumatoid arthritis (RA)
8 September 2014 | By Roche
Roche announced that RoACTEMRA (tocilizumab) has received approval from the European Commission for use in patients with severe, active and progressive RA who previously have not been treated with methotrexate...